Recent spatial proteomic studies, targeting 40-50 proteins in human tumours, revealed gradients of histological features such as grade and morphology that coincided with protein gradients in colorectal cancer [29], and immunological correlates of complete response to therapy in HER2+ breast cancer [30]. Here, ERBB2 is linked to breast carcinoma.